Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets - PubMed (original) (raw)
- PMID: 6603475
- PMCID: PMC1129180
- DOI: 10.1172/jci110964
Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets
Y Oka et al. J Clin Invest. 1983 Jul.
Abstract
Human epidermal growth factor (hEGF) has previously been isolated from urine and probably is identical to human beta-urogastrone (hUG). Immunoreactive hEGF/UG has been found in the plasma of normal subjects. In this study, using immunoaffinity chromatography to extract hEGF/UG from plasma, we found that immunoreactive hEGF/UG in blood was associated with blood platelets. It was present in platelet-rich, but not platelet-poor plasma and serum, and was found predominantly in the platelet fraction of whole blood. Sephadex G-50 Fine gel-exclusion chromatography of an extract of outdated blood bank platelets revealed two hEGF/UG components, one of which eluted in the void volume, and the other of which coeluted with purified standard hEGF/UG. The former hEGF/UG component was a high-molecular weight form that was cleaved into hEGF/UG by incubation with either mouse EGF/UG-associated arginine esterase or trypsin. It appeared to be identical to the high-molecular weight hEGF/UG previously reported in human urine, except for its apparently equal activities in radioimmunoassay and radioreceptor assay. The latter hEGF/UG component was immunologically, biologically, and physiochemically indistinguishable from highly purified hEGF/UG from human urine and was immunologically different from purified human platelet-derived growth factor. Platelet-associated hEGF/UG may account for the mitogenic activity of serum in cell lines in which platelet-derived growth factor is not active. Since hEGF/UG appears to be liberated from platelets during coagulation, platelet-associated EGF/UG may be involved in normal vascular and tissue repair and in the pathogenesis of atherosclerotic lesions. The discovery that the EGF/UG in plasma is associated with blood platelets raises important new possibilities for its role in human health and disease.
Similar articles
- Purification and characterization of epidermal growth factor (beta-urogastrone) and epidermal growth factor fragments from large volumes of human urine.
Mount CD, Lukas TJ, Orth DN. Mount CD, et al. Arch Biochem Biophys. 1985 Jul;240(1):33-42. doi: 10.1016/0003-9861(85)90005-0. Arch Biochem Biophys. 1985. PMID: 3874599 - Epidermal growth factor (urogastrone) in human tissues.
Hirata Y, Orth DN. Hirata Y, et al. J Clin Endocrinol Metab. 1979 Apr;48(4):667-72. doi: 10.1210/jcem-48-4-667. J Clin Endocrinol Metab. 1979. PMID: 219006 - Immunoreactive human epidermal growth factor in human pancreatic juice.
Hirata Y, Uchihashi M, Nakajima M, Fujita T, Matsukura S. Hirata Y, et al. J Clin Endocrinol Metab. 1982 Jun;54(6):1242-5. doi: 10.1210/jcem-54-6-1242. J Clin Endocrinol Metab. 1982. PMID: 6978887
Cited by
- Evidence for glomerular actions of epidermal growth factor in the rat.
Harris RC, Hoover RL, Jacobson HR, Badr KF. Harris RC, et al. J Clin Invest. 1988 Sep;82(3):1028-39. doi: 10.1172/JCI113659. J Clin Invest. 1988. PMID: 3262122 Free PMC article. - Action of epidermal growth factor on acid secretion by rat isolated parietal cells.
Shaw GP, Hatt JF, Anderson NG, Hanson PJ. Shaw GP, et al. Biochem J. 1987 Jun 15;244(3):699-704. doi: 10.1042/bj2440699. Biochem J. 1987. PMID: 2451501 Free PMC article. - The Platelet Response to Tissue Injury.
Eisinger F, Patzelt J, Langer HF. Eisinger F, et al. Front Med (Lausanne). 2018 Nov 13;5:317. doi: 10.3389/fmed.2018.00317. eCollection 2018. Front Med (Lausanne). 2018. PMID: 30483508 Free PMC article. Review. - A new serum-free method of measuring growth factor activities for human breast cancer cells in culture.
Ogasawara M, Sirbasku DA. Ogasawara M, et al. In Vitro Cell Dev Biol. 1988 Sep;24(9):911-20. doi: 10.1007/BF02623902. In Vitro Cell Dev Biol. 1988. PMID: 3049518 - Epidermal growth factor, a vascular smooth muscle mitogen, induces rat aortic contraction.
Berk BC, Brock TA, Webb RC, Taubman MB, Atkinson WJ, Gimbrone MA Jr, Alexander RW. Berk BC, et al. J Clin Invest. 1985 Mar;75(3):1083-6. doi: 10.1172/JCI111772. J Clin Invest. 1985. PMID: 3872314 Free PMC article.
References
- J Biol Chem. 1962 May;237:1555-62 - PubMed
- Nature. 1970 Aug 15;227(5259):680-5 - PubMed
- J Biol Chem. 1974 May 25;249(10):3198-203 - PubMed
- Exp Cell Res. 1976 Mar 1;98(1):170-4 - PubMed
- Hoppe Seylers Z Physiol Chem. 1975 Nov;356(11):1765-74 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources